2025-12-03T15:44:26-06:00 2024-12-31 882730877 CHERRY BEKAERT ADVISORY LLC 6116 EXECUTIVE BLVD STE 600 ROCKVILLE MD 20852 990 2024-01-01 311671642 ASSOCIATION FOR MOLECULAR PATHOLOGY INC ASSO 3016347987 6120 EXECUTIVE BLVD SUITE 700 ROCKVILLE MD 20852 LAUREN S MENSER CHIEF EXECUTIVE OFFICER 3016347987 2025-12-03 1 0 BREE-ANN WEIDNER P01319397 3015899000 2024 2025-03-06 01:10:19Z LAUREN S MENSER 6120 EXECUTIVE BLVD SUITE 700 ROCKVILLE MD 20852 7327389 0 X WWW.AMP.ORG X 1999 MD THE ASSOCIATION FOR MOLECULAR PATHOLOGY IS A NOT-FOR-PROFIT SCIENTIFIC SOCIETY THAT ADVANCES THE CLINICAL PRACTICE, SCIENCE, AND EXCELLENCE OF MOLECULAR AND GENOMIC LABORATORY MEDICINE THROUGH EDUCATION, INNOVATION, AND ADVOCACY TO ENABLE HIGHEST QUALITY HEALTH CARE. 19 19 20 411 147050 0 1239490 1047214 4775298 4841831 352653 388344 0 0 6367441 6277389 46186 37425 0 0 2867119 2756879 0 0 0 3549583 4696891 6462888 7491195 -95447 -1213806 16076546 15519539 2992958 3038225 13083588 12481314 X ADVANCES THE CLINICAL PRACTICE, SCIENCE, AND EXCELLENCE OF MOLECULAR AND GENOMIC LABORATORY MEDICINE THROUGH EDUCATION, INNOVATION, AND ADVOCACY TO ENABLE HIGHEST QUALITY HEALTH CARE. 0 0 2845984 37425 4154655 SCIENTIFIC SYMPOSIA AND MEETINGS - SEE SCHEDULE O FOR COMPLETE DESCRIPTION 320975 467403 COMMUNICATION & OUTREACH: MEMBERSHIP SERVICES - WEBSITE, NEWSLETTERS, ETC.PROMOTE GENERAL EFFECTIVENESS AND PROVIDE A FORUM FOR DISCUSSION AND A MEANS OF EXCHANGING INFORMATION. 558685 72723 INNOVATION AND IMPROVED PATIENT CARE (IIPC) - SEE SCHEDULE O FOR COMPLETE DESCRIPTIONIIPC WORKS TO FOSTER INNOVATION TO IMPROVE PATIENT CARE AND PATIENT OUTCOMES THROUGH PROGRAMS THAT INCLUDE ISSUING MANUSCRIPTS, CLINICAL PRACTICE GUIDELINES, REPORTS, AND OVERSIGHT OF JMD'S STRATEGIC DIRECTION.THE JOURNAL OF MOLECULAR DIAGNOSTICSTHIS IS THE OFFICIAL JOURNAL OF AMP. MONTHLY PUBLICATION BEGAN IN JANUARY 2020. THESE ISSUES HAVE ORIGINAL, HIGH-QUALITY MANUSCRIPTS ON SCIENTIFIC ADVANCES IN THE TRANSLATION AND VALIDATION OF MOLECULAR DISCOVERIES IN MEDICINE INTO THE CLINICAL DIAGNOSTIC SETTING, AND THE DESCRIPTION AND APPLICATION OF TECHNOLOGICAL ADVANCES IN THE FIELD OF MOLECULAR DIAGNOSTIC MEDICINE.EVERY PUBLISHED MANUSCRIPT IS SCIENTIFICALLY PEER REVIEWED.JMD IS JOINTLY OWNED WITH THE AMERICAN SOCIETY FOR INVESTIGATIVE PATHOLOGY (ASIP) 94-6079945. STARTING IN 2011, ELSEVIER BEGAN PUBLISHING JMD. 1862651 ADVOCACYTHE AMP ADVOCACY PROGRAM ENDEAVORS TO INFORM AND INFLUENCE PUBLIC POLICY AFFECTING MOLECULAR PATHOLOGY. AMP REPRESENTS ITS MEMBERSHIP TO THE FEDERAL AGENCIES AND MEMBERS OF CONGRESS REGARDING PROFESSIONAL AND REIMBURSEMENT ISSUES - REACHING OUT TO FELLOW PROFESSIONAL ASSOCIATIONS, INDUSTRY AND OTHER ASSOCIATION PARTNERS TO ACCOMPLISH COMMON GOALS. 1862651 5588295 1 1 0 1 0 0 0 0 0 0 1 0 0 1 1 0 1 0 0 0 1 0 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 41 0 1 20 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 19 19 0 0 0 0 1 1 0 1 1 0 0 1 1 1 1 1 1 1 0 0 X LAUREN S MENSER 3016347987 6120 EXECUTIVE BLVD SUITE 700 ROCKVILLE MD 20852 MARIA E ARCILA MD PRESIDENT (1/1-11/23/24) 2.00 0.00 X X 0 0 0 LAURA J TAFE MD PAST PRES & NOMINATING (1/1-11/23/24) 2.00 0.00 X X 0 0 0 JANE S GIBSON MS PHD PRES ELECT:AWARD&STRAT (1/1-11/23/24) 2.00 0.00 X X 0 0 0 YASSMINE MN AKKARI PHD SECRETARY-TREASURER 2.00 0.00 X X 0 0 0 YAOLIN ZHOU MD MEM AFFAIRS COMM (1/1-11/23/24) 2.00 0.00 X 0 0 0 ERIC KONNICK MD MS PROFESSIONAL RELATIONS COM 2.00 0.00 X 0 0 0 MARJORIE DAVID MD MS TRAINING & EDUCATION COMM 2.00 0.00 X 0 0 0 KRISTEN ST GEORGE MAPPSC PHD INFECT DIS SUBDIV (1/1/-11/23/24) 2.00 0.00 X 0 0 0 SUSAN H HSIAO MD PHD CLINICAL PRAC COMM (1/1-11/23/24) 2.00 0.00 X 0 0 0 MATTHEW LEBO PHD GENETICS SUBDIV CHAIR (1/1-11/23/24) 2.00 0.00 X 0 0 0 ANNETTE LEON PHD MSC INFO SUBDIV CHAIR (1/1-11/23/24) 2.00 0.00 X 0 0 0 JAY PATEL MD ECONOMIC AFFAIRS COMMITTEE 2.00 0.00 X 0 0 0 JONATHAN NOWAK MD PHD PROG COMM CHAIR (1/1-11/23/24) 2.00 0.00 X 0 0 0 PATRICIA TSANG MD PUBLICATION/COMMUNICATION 2.00 0.00 X 0 0 0 RENA R XIAN MD HEMATOPATHOLOGY SUBDIVISIO 2.00 0.00 X 0 0 0 ANTHONY N SNOW MD SOLID TUMORS SUBDIVISION C 2.00 0.00 X 0 0 0 RAMI MAHFOUZ MD MPH INTERNATIONAL AFFAIRS COMM 2.00 0.00 X 0 0 0 ADAM FISCH MD PHD EARLY CAREER MEMBER 2.00 0.00 X 0 0 0 PANIEH TERRAF PHD EARLY CAREER MEMBER 1/1-11/23/24) 2.00 0.00 X 0 0 0 JANE S GIBSON MS PHD PRESIDENT (START 11/24/24) 2.00 0.00 X X 0 0 0 AARON BOSSLER MD PHD PRES ELECT: AWAR&STRAT(START 11/24/24) 2.00 0.00 X X 0 0 0 MARIA E ARCILA MD PAST PRES/NOM CHAIR (START 11/24/24) 2.00 0.00 X X 0 0 0 ALANNA CHURCH MD CLIN PRAC COMM CHAIR (START 11/24/24) 2.00 0.00 X 0 0 0 EMILIA CALVARESI MD PHD EARLY CAREER REPR (START 11/24/24) 2.00 0.00 X 0 0 0 JENNIFER MORRISSETTE PHD MEM AFF COMM CHAIR (START 11/24/24) 2.00 0.00 X 0 0 0 SOMAK ROY MD PROG COMM CHAIR (START 11/24/24) 2.00 0.00 X 0 0 0 KRISTY CROOKS PHD GEN SUBDIV CHAIR (START 11/24/24) 2.00 0.00 X 0 0 0 JOSEPH YAO MD INF DIS SUBDIV CHAIR (START 11/24/24) 2.00 0.00 X 0 0 0 JULIE HIRSCHHORN PHD INFO SUBDIV CHAIR (START 11/24/24) 2.00 0.00 X 0 0 0 MARY STEELE WILLIAMS MNA MT ASCPSM EXECUTIVE DIRECTOR (THRU 1/2/24) 40.00 0.00 X 52854 0 1859 LAUREN S MENSER CHIEF EXECUTIVE OFFICER-START 1/3/24 40.00 0.00 X 342611 0 43226 ROBYN TEMPLE-SMOLKIN DIR CLINICAL/SCIENTIFIC AF 40.00 0.00 X 160987 0 43316 SARA HAMILTON DIRECTOR OF MEETINGS & EXH 40.00 0.00 X 156152 0 25112 ERIKO CLEMENTS DIRECTOR OF EDUCATION PROG 40.00 0.00 X 141177 0 36713 MICHELE ZINK DIRECTOR OF GOVERNANCE & O 40.00 0.00 X 141500 0 23726 ANNA MARIA SCRIMENTI DIR PUBLIC POLICY & ADVOCACY 40.00 0.00 X 145099 0 23457 1140380 0 197409 6 0 1 0 HYMAN PHELPS & MCNAMARA PC 700 THIRTEENTH STREET NW SUITE WASHINGTON DC 20005 LEGAL SERVICES 1108648 BC PAVILION CORPORATION DBA VANCOUVER 999 CANADA PLACE SUITE 200 VANCOUVER BRITISH COLUMBIA CA V6C 3C1 FOOD/BEVERAGE/AUDIO-VISUAL/MISC 631736 INNOVATION POLICY SOLUTIONS LLC 1032 15TH STREET NW SUITE 252 WASHINGTON DC 20005 GOVERNMENT RELATIONS 282000 THE EXPO GROUP INC 5931 CAMPUS CIRCLE DRIVE IRVING TX 75063 GENERAL SERVICE CONTRACTOR-EXHIBITS 148278 4 1047214 1047214 EDUCATION 541900 4298635 4151585 147050 MEMBERSHIP DUES 541900 431687 431687 JMD PROGRAM 541900 72723 72723 MAILING LIST RENTALS 541900 35250 35250 OTHER PROGRAM REVENUE 541900 3536 3536 4841831 388344 388344 1050000 1050000 0 6277389 4694781 147050 388344 19490 19490 17935 17935 440550 290531 150019 1777270 1178458 598812 213731 122340 91391 168990 125196 43794 156338 107998 48340 1109781 1108648 1133 72630 22500 50130 31698 31698 58386 58386 557573 425169 132404 39685 22268 17417 268900 153569 115331 123402 24119 99283 264727 264727 76333 64920 11413 1848467 1829168 19299 121671 121671 39535 21233 18302 CORPORATE PARTNERSHIP 61013 61013 PROJECT SUPPORT 19790 19755 35 GRASSROOTS COMMUNICATIO 3300 3300 7491195 5588295 1902900 0 2001724 1693978 174621 249880 144324 131877 906722 743607 283732 163115 12219115 12109606 1253030 1171083 16076546 15519539 625618 543810 867982 1228216 1499358 1266199 2992958 3038225 X 12929172 12440045 154416 41269 13083588 12481314 16076546 15519539 -1213806 610532 1000 0 X 0 1 X 1 0 X 925395 2102840 2271272 1239490 1047214 7586211 2827834 1946652 4296408 4712448 4694781 18478123 3753229 4049492 6567680 5951938 5741995 26064334 0 88480 383058 471538 88480 383058 471538 25592796 184051 197981 202434 345059 388344 1317869 184051 197981 202434 345059 388344 1317869 3937280 4247473 6770114 6296997 6130339 27382203 0.93470 0.95500 0.04810 0.04180 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 5047 62197 67244 7217534 7284778 514239 128560 0 0 369656 436912 470584 514239 1791391 2687087 47303 88978 63396 67244 266921 92414 109228 117646 128560 447848 671772 4196 3995 5620 5047 18858 906722 743607 163115 163115 SECURITY DEPOSIT 19565 INVESTMENTS HELD IN TRUST - 457(B) 121445 ROU ASSET 1030073 1171083 LEASE LIABILTY 1266199 1266199 6829535 610532 610532 6219003 58386 58386 6277389 7431809 -1000 -1000 7432809 58386 58386 7491195 1 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 PROGRAM SERVICES SCIENTIFIC SYMPOSIA AND MEETINGS (AMP EUROPE 2024) 353198 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 PROGRAM REVENUE EDUCATION (AMP EUROPE 2024) 308663 SOUTH AMERICA 0 0 PROGRAM SERVICES SCIENTIFIC SYMPOSIA AND MEETINGS (AIPM AFFILATE SPEAKER SUPPORT) 3000 NORTH AMERICA 0 0 PROGRAM SERVICES SCIENTIFIC SYMPOSIA AND MEETINGS (AIPM AFFILATE SPEAKER SUPPORT) 40000 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTS 1433 NORTH AMERICA 0 0 GRANTS 1336 SOUTH ASIA 0 0 GRANTS 3654 SUB-SAHARAN AFRICA 0 0 GRANTS 2330 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 GRANTS 9182 NORTH AMERICA 0 0 PROGRAM SERVICES SCIENTIFIC SYMPOSIA AND MEETINGS (AMP ANNUAL MEETING & EXPO) 874119 0 0 0 0 0 0 713614 883301 1596915 GLOBAL IMPACT TRAVEL AWARD SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL, 1 720 WIRE TRANSFER BOOK INTERNATIONAL TRAINEE TRAVEL AWARD EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIU 2 5623 WIRE TRANSFER BOOK INTERNATIONAL TRAINEE TRAVEL AWARD SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL, 1 2934 WIRE TRANSFER BOOK GLOBAL IMPACT TRAVEL AWARD MIDDLE EAST AND NORTH AFRICA 1 1433 WIRE TRANSFER BOOK GLOBAL IMPACT TRAVEL AWARD SUB-SAHARAN AFRICA 1 2330 WIRE TRANSFER BOOK TECHNOLOGIST TRAVEL AWARD NORTH AMERICA 1 836 WIRE TRANSFER BOOK TECHNOLOGIST POSTER NORTH AMERICA 1 500 WIRE TRANSFER BOOK GLOBAL YOUNG INVESTIGATOR POSTER EUROPE (INCLUDING ICELAND & GREENLAND) 1 1000 WIRE TRANSFER BOOK GLOBAL YOUNG INVESTOGATOR TRAVEL EUROPE (INCLUDING ICELAND & GREENLAND) 2 2559 WIRE TRANSFER BOOK 0 0 0 0 0 0 PART I, LINE 2: ASSOCIATION FOR MOLECULAR PATHOLOGY HAS AN AWARDS COMMITTEE WHICH CHOOSES AWARD RECIPIENTS AND MONITORS THE USE OF THOSE AWARDS. THE COMMITTEE ACCEPTS NOMINATIONS FROM THE MEMBERSHIP AND COMPILES SUGGESTIONS FROM THE COMMITTEE AS WELL. MEETING-SPECIFIC AWARD APPLICATIONS ARE REVIEWED BY THE RELEVANT COMMITTEE FOR SELECTION. THOSE SELECTED PROVIDE PROOF OF MEETING THE REQUIREMENTS BEFORE PAYMENT IS PROVIDED. 1 TECHNOLOGIST POSTER 11 2500 TECHNOLOGIST TRAVEL 5 7490 GLOBAL YOUNG INVESTIGATOR POSTER 2 2000 GLOBAL YOUNG INVESTIGATOR TRAVEL 1 2000 YOUNG INVESTIGATOR 3 3000 LEADERSHIP 1 2500 PART I, LINE 2: ASSOCIATION FOR MOLECULAR PATHOLOGY HAS AN AWARDS COMMITTEE WHICH CHOOSES AWARD RECIPIENTS AND MONITORS THE USE OF THOSE AWARDS. THE COMMITTEE ACCEPTS NOMINATIONS FROM THE MEMBERSHIP AND COMPILES SUGGESTIONS FROM THE COMMITTEE AS WELL. THE AWARD FOR EXCELLENCE RECIPIENTS ARE SELECTED TWO YEARS PRIOR TO THE AWARD BEING PRESENTED AT THE AMP ANNUAL MEETING & EXPO. THE RECIPIENT OF THE AWARD PRESENTS A SPECIAL LECTURE AT THE MEETING. MEETING-SPECIFIC AWARD APPLICATIONS ARE REVIEWED BY THE RELEVANT COMMITTEE FOR SELECTION. THOSE SELECTED PROVIDE PROOF OF MEETING THE REQUIREMENTS BEFORE PAYMENT IS PROVIDED. X 1 1 X X X X 0 0 0 0 0 0 0 0 0 LAUREN S MENSER CHIEF EXECUTIVE OFFICER-START 1/3/24 342611 0 0 0 0 0 30000 0 13226 0 385837 0 0 0 ROBYN TEMPLE-SMOLKIN DIR CLINICAL/SCIENTIFIC AF 160987 0 0 0 0 0 16068 0 27248 0 204303 0 0 0 SARA HAMILTON DIRECTOR OF MEETINGS & EXH 156152 0 0 0 0 0 14768 0 10344 0 181264 0 0 0 ERIKO CLEMENTS DIRECTOR OF EDUCATION PROG 141177 0 0 0 0 0 13792 0 22921 0 177890 0 0 0 ANNA MARIA SCRIMENTI DIR PUBLIC POLICY & ADVOCACY 145099 0 0 0 0 0 13520 0 9937 0 168556 0 0 0 MICHELE ZINK DIRECTOR OF GOVERNANCE & O 141500 0 0 0 0 0 13390 0 10336 0 165226 0 0 0 PART I, LINE 1A PER THE EMPLOYMENT CONTRACT, THE CHIEF EXECUTIVE OFFICER HAS USE OF A DISCRETIONARY EXPENSE ACCOUNT, UP TO $10,000 PER YEAR, FOR OFFICE AND UPGRADED BUSINESSS TRAVEL EXPENSES, PROFESSIONAL DEVELOPMENT AND INDIVIDUAL LONG TERM CARE INSURANCE. THE FUNDS ARE NOT TAXABLE TO THE EXECUTIVE DIRECTOR. FORM 990, PART III, LINE 4A SCIENTIFIC SYMPOSIA AND MEETINGS THE ORGANIZATION BRINGS TOGETHER SCIENTISTS FOR THE PROMOTION OF CLINICAL PRACTICE, BASIC RESEARCH, AND EDUCATION IN MOLECULAR PATHOLOGY. IN 2024, AMP'S ANNUAL MEETING & EXPO WAS HELD IN VANCOUVER, BRITISH COLUMBIA, CANADA. THIS THREE-DAY EVENT FEATURED MORE THAN 25 HOURS OF CUTTING-EDGE SESSIONS, 507 POSTERS, 153 EXHIBITORS, AND COUNTLESS OPPORTUNITIES TO INTERACT DIRECTLY WITH COLLEAGUES. THERE WERE 1768 REGISTRANTS. IN NOVEMBER 2024, AMP HELD GET AMPED!, A LIVE EDUCATIONAL AND INTERACTIVE COURSE DESIGNED TO BRING ATTENDEES UP TO SPEED IN MOLECULAR PATHOLOGY. THE THEME OF THE COURSE WAS, "NEW, EMERGING, AND TRIED AND TRUE TECHNOLOGIES IN MOLECULAR PATHOLOGY WITH INTERACTIVE CASE STUDIES." THE COURSE LEARNING OBJECTIVES WERE TO: - DESCRIBE THE MECHANISM OF OPTICAL GENOME MAPPING AND ITS IMPORTANT APPLICATIONS IN HEMATOLOGICAL MALIGNANCIES AND SOLID TUMORS; - DESCRIBE THE ROLE OF INFORMATICS IN PROCESSING CLINICAL MOLECULAR DATA; - FACULTY MEMBERS PRESENT AN IMMERSIVE WORKSHOP OF CASE STUDIES WHERE PARTICIPANTS BREAK OUT INTO SMALL GROUPS TO WORK THROUGH CLINICAL MOLECULAR CASES. MOLECULAR GENETIC PATHOLOGY REVIEW COURSE AMP HAD ITS FIRST MGP REVIEW COURSE IN 2007. IT THEN HAD A LIVE EVENT IN THE ODD YEARS FROM 2009 THROUGH 2023. STARTING IN 2021, THE COURSE WAS PROVIDED AS A LIVE VIRTUAL EVENT. THE LIVE EVENT WAS RECORDED STARTING IN 2017 AND OFFERED AS AN ONLINE COURSE UNTIL THE NEXT LIVE COURSE WAS OFFERED. THE REVENUE FROM RECORDED SESSIONS IS ACCOUNTED FOR IN ONLINE EDUCATION. THE COURSE FEATURES MULTI-DAY INTENSE INSTRUCTION ON UPDATES IN THE FIELD AND REVIEW OF MOLECULAR PATHOLOGY CORE CONCEPTS THAT IS PRIMARILY FOCUSED ON PREPARATION FOR THE MOLECULAR GENETIC PATHOLOGY (MGP) SUBSPECIALTY CERTIFICATION EXAM, AS WELL AS OTHER CERTIFICATION EXAMS. AMP EUROPE 2024 WAS HELD IN MADRID, SPAIN ON JUNE 24 TO 26, WITH 306 ATTENDEES, 16 EXHIBITORS, 18 EDUCATIONAL SESSIONS (PLUS 7 INDUSTRY SYMPOSIA) AND 105 POSTERS. AWARDS WERE PRESENTED FOR TRAVEL SUPPORT AND YOUNG INVESTIGATOR POSTER PRESENTATION. FORM 990, PART VI, SECTION A, LINE 6 THE FOLLOWING ARE AMP'S MEMBERSHIP CATEGORIES: SEE WWW.AMP.ORG/MEMBERSHIP/JOIN-RENEW/ FOR ADDITIONAL DESCRIPTIONS. 1) REGULAR MEMBERS 2) TECHNOLOGIST MEMBERS 3) EARLY CAREER MEMBERS 4) ASSOCIATE MEMBERS (STUDENTS, FELLOWS, RESIDENTS) 5) EMERITUS MEMBERS (RETIRED REGULAR MEMBERS) 1) REGULAR MEMBERS ARE INDIVIDUALS INVOLVED IN THE EDUCATIONAL, MEDICAL, SCIENTIFIC, ECONOMIC, AND/OR REGULATORY ASPECTS OF MOLECULAR DIAGNOSTICS, INCLUDING BUT NOT LIMITED TO PATHOLOGISTS, CLINICAL LABORATORY SCIENTISTS, TECHNOLOGISTS, CLINICIANS AND OTHER HEALTH CARE PERSONNEL, GOVERNMENT EMPLOYEES, ESPECIALLY THOSE INVOLVED IN REGULATION OF THE FIELD, AND PROFESSIONALS IN THE IN VITRO DIAGNOSTICS INDUSTRY. REGULAR MEMBERS ARE ELIGIBLE TO VOTE, TO HOLD ELECTED OFFICE, AND TO SERVE ON AMP COMMITTEES. DUES RATES FOR REGULAR MEMBERS VARY DEPENDING ON THE INDIVIDUAL'S COUNTRY OF RESIDENCE AND PLACE OF EMPLOYMENT. VISIT THE MEMBERSHIP DUES RATES PAGE FOR DETAILS. 2) TECHNOLOGIST MEMBERS ARE INDIVIDUALS INVOLVED IN THE CLINICAL PRACTICE AND/OR RESEARCH ASPECTS OF MOLECULAR DIAGNOSTICS WHOSE PRIMARY DUTIES INVOLVE BENCH WORK, DEVELOPING AND/OR PERFORMING TESTS. TECHNOLOGIST MEMBERS ARE ELIGIBLE TO VOTE, TO HOLD ELECTED OFFICE, AND TO SERVE ON AMP COMMITTEES. DUES RATES FOR TECHNOLOGIST MEMBERS VARY DEPENDING ON THE INDIVIDUAL'S COUNTRY OF RESIDENCE AND PLACE OF EMPLOYMENT. VISIT THE MEMBERSHIP DUES RATES PAGE FOR DETAILS. 3) EARLY CAREER MEMBERS ARE INDIVIDUALS WHO WERE ASSOCIATE MEMBERS LAST YEAR AND ARE TRANSITIONING TO REGULAR MEMBER STATUS. DUES RATES FOR EARLY CAREER MEMEBERS VARY DEPENDING ON THE INDIVIDUAL'S COUNTRY OF RESIDENCE AND PLACE OF EMPLOYMENT. VISIT THE MEMBERSHIP DUES RATES PAGE FOR DETAILS. 4) ASSOCIATE MEMBERSHIP IS OPEN TO TRAINEES (CURRENTLY ENROLLED STUDENTS, POSTDOCTORAL FELLOWS, AND RESIDENTS). ASSOCIATE MEMBERSHIP CARRIES ALL THE BENEFITS OF FULL MEMBERSHIP EXCEPT HOLDING ELECTED OFFICE AND VOTING RIGHTS IN AMP ELECTIONS. AN APPLICANT MUST PROVIDE A VERIFICATION OF TRAINEE STATUS FROM THEIR PROGRAM DIRECTOR OR INSTITUTION UPON JOINING AND RENEWING MEMBERSHIP AS AN ASSOCIATE MEMBER. 5) EMERITUS MEMBERSHIP IS OPEN TO REGULAR MEMBERS WHO ARE RETIRED AND ARE NO LONGER RECEIVING EITHER FULL OR PART-TIME SALARY FROM AN INSTITUTION, COMPANY OR ORGANIZATION. CANDIDATES FOR THIS CATEGORY MUST HAVE BEEN A REGULAR AMP MEMBER FOR AT LEAST THE FIVE CONSECUTIVE YEARS IMMEDIATELY PRECEDING APPLICATION FOR EMERITUS STATUS. EMERITUS MEMBERSHIP CARRIES ALL THE BENEFITS OF FULL MEMBERSHIP EXCEPT THE ABILITY TO RUN FOR ELECTED OFFICE OR VOTE IN SOCIETY ELECTIONS. NOTE: AMP RESERVES THE RIGHT TO ACTIVATE OR INACTIVATE MEMBERSHIPS, IN ACCORDANCE WITH AMP BYLAWS AND OPERATING PROCEDURES. FORM 990, PART VI, SECTION A, LINE 7A THE MAJORITY OF THE BOARD OF DIRECTORS IS ELECTED BY AMP'S MEMBERSHIP. ONLY AMP'S REGULAR MEMBERS MAY RUN FOR OFFICE. FORM 990, PART VI, SECTION B, LINE 11B AMP'S FORM 990 IS INITIALLY REVIEWED, IN DRAFT FORM, BY THE CHIEF EXECUTIVE OFFICER. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICTS OF INTEREST DISCLOSURE REPORTS ARE GIVEN TO THE CHIEF EXECUTIVE OFFICER. THE CHIEF EXECUTIVE OFFICER THEN MONITORS THE ISSUES AND ALERTS THE PRESIDENT AND RELEVANT COMMITTEE CHAIR OF ANY APPARENT CONFLICTS. FORM 990, PART VI, SECTION B, LINE 15A THE COMPENSATION OF THE CHIEF EXECUTIVE OFFICER IS APPROVED BY THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION C, LINE 19 AMP'S BYLAWS ARE AVAILABLE ON THE AMP WEBSITE.